timothy sykes logo

Stock News

Lantheus Stock Jumps as Truist Upgrades Rating and Raises Price Target

Jack KelloggAvatar
Written by Jack Kellogg Reviewed by Ellis Hobbs Fact-checked by Matt Monaco
Updated 12/13/2025, 11:22 am ET 12/13/2025, 11:22 am ET | 4 min 4 min read
Lantheus Stock Jumps as Truist Upgrades Rating and Raises Price Target Thumbnail

Lantheus Holdings Inc.’s stocks have been trading up by 5.39 percent after promising results boosted investor confidence.

Healthcare industry expert:

Analyst sentiment – positive

Lantheus Holdings (LNTH) holds a solid market position within the healthcare sector, buoyed by strong financial fundamentals. The company’s robust gross margin of 62.2% and an EBITDA margin of 19.5% highlight its efficiency in converting revenue into profit. With revenue soaring to approximately $1.53 billion, there’s noticeable growth over both a three-year (23.94%) and five-year period (35.46%). However, the current P/E ratio of 26.62, coupled with a price-to-sales ratio of 2.74, suggests the stock may be overvalued relative to its earnings, yet reasonable given its growth trajectory and profitability ratios. Finally, a commendable total debt-to-equity ratio of 0.51 indicates sound financial health and strong operational leverage conducive to further expansion.

Examining the technical landscape, LNTH exhibits bullish tendencies, with recent weekly price data showcasing robust resistance near $66.50 after a pronounced gap up from $60.43 to $66.62. The stock’s upward movement aligned with increasing volumes reaffirms growing investor confidence, particularly following a closing price of $66.50. The dominant trend remains positive, with short-term traders advised to capitalize on pullbacks near $63.10 to enter a long position. Resistance is firmly positioned around the recent highs, with stop-losses optimally placed just below $62.27, supporting a favorable risk-reward ratio in current market dynamics.

Recent developments, specifically the upgrade to a ‘Buy’ rating by Truist with an $80 target, signify a re-acceleration of profit projections, contributing to a surge in stock price by approximately 5.3%. This analyst upgrade, coupled with an enhanced outlook for Q4 and FY27, suggests Lantheus is poised for a robust acceleration in revenue and EPS growth. Comparatively, Lantheus outperforms its healthcare and pharmaceuticals peers, buoyed by strategic advancements and unrecognized growth potential. Resistance is evident at $80, yet if breached, further upside could be anticipated. Overall, Lantheus Holdings is well-positioned for continued growth, stemming from its financial strength and positive market sentiment.

Candlestick Chart

Weekly Update Dec 08 – Dec 12, 2025: On Saturday, December 13, 2025 Lantheus Holdings Inc. stock [NASDAQ: LNTH] is trending up by 5.39%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

Lantheus Holdings shows promising financial strength, underpinned by a compelling mix of profitability and growth metrics. The company’s EBITDA margin stands at 19.5%, reflecting efficient operation management. Recent financial reports reveal a total revenue of approximately $1.53B, underscoring a solid topline. However, the Price-to-Earnings (P/E) ratio at 26.62 indicates an above-average valuation, suggesting market confidence in future earnings growth. Analysts also highlight the company’s robust EBIT margin of 17.2% and a gross margin of 62.2%, advocating its operational efficacy.

The company’s stock performance has been volatile, as reflected in recent price fluctuations. The stock moved from an opening price of $62.27 to close at $67.35 in the latest trading period, showing significant intra-day gains. This jump is substantial considering the typical trading volume, which hints at heightened investor engagement following favourable news coverage. Furthermore, the upgraded price target by Truist aligns with the company’s strategic outlook for Q4 and FY 2027, bolstering investor confidence.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

How much has this post helped you?

(0 votes, average: 0 out of 5)
Leave a reply
Author card Timothy Sykes picture

Jack Kellogg

He teaches webinars on Tim Sykes’ Trading Challenge He became Tim’s youngest millionaire student in 2020. Now he’s second on the Trading Challenge leaderboard with $12.9 million in career earnings. He’s a master of the 7-Step Pennystocking Framework. Jack is one of a rare breed of traders to profitably trade the entire penny stock framework.
Read More

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”